Clinical Trial Update: A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating SHR-1905 for severe uncontrolled asthma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SHR-1905

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Asthma | Phase 3 | Status: RECRUITING